Selected article for: "diagnostic test and high throughput"

Author: Subali, A. D.; Wiyono, L.
Title: Reverse Transcriptase Loop Mediated Isothermal Amplification (RT-LAMP) for COVID-19 Diagnosis: A Systematic Review and Meta-Analysis
  • Cord-id: g5vgr2pj
  • Document date: 2021_1_6
  • ID: g5vgr2pj
    Snippet: Background Coronavirus Disease 2019 (COVID-19) has caused a severe outbreak and become a global public health priority. Rapid increment of infection number along with significant deaths have placed the virus as a serious threat to human health. Rapid, reliable, and simple diagnostic methods are critically essential for disease control. While Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is the current diagnostic gold standard, Reverse Transcriptase LoopMediated Isothermal Amplificatio
    Document: Background Coronavirus Disease 2019 (COVID-19) has caused a severe outbreak and become a global public health priority. Rapid increment of infection number along with significant deaths have placed the virus as a serious threat to human health. Rapid, reliable, and simple diagnostic methods are critically essential for disease control. While Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is the current diagnostic gold standard, Reverse Transcriptase LoopMediated Isothermal Amplification (RT-LAMP) appears as a compelling alternative diagnostic test due to its more simplicity, shorter time to result, and lower cost. This study examined RT-LAMP application for rapid identification of SARS-CoV-2 infection compared to RT-PCR assay. Methods A systematic review and meta-analysis (2020) was conducted in 6 scientific databases following the PRISMA Guideline. Original published studies on human clinical samples in English were included. Articles evaluated sensitivity and specificity of RT-LAMP relative to RT-PCR were considered eligible. Quality assessment of bias and applicability was examined based on QUADAS-2. Results A total of 351 studies were found based on the keywords and search queries. 14 eligible case control studies fitted the respective criteria. Quality assessment using QUADAS-2 indicated low risk bias in all included studies. All case studies, comprises 2,112 samples, had the cumulative sensitivity of 95.5% (CI 97.5%=90.8-97.9%) and cumulative specificity of 99.5% (CI 97.5%=97.7-99.9%). Conclusion RT-LAMP assay could be suggested as a reliable alternative COVID-19 diagnostic method with reduced cost and time compared to RT-PCR. RT-LAMP could potentially be utilized during the high-throughput and high-demand critical situations.

    Search related documents:
    Co phrase search for related documents
    • abstract screening and acid testing: 1
    • abstract screening and acute respiratory: 1, 2, 3, 4, 5
    • abstract screening and acute sars cov respiratory syndrome coronavirus: 1, 2
    • abstract screening and low concern: 1
    • abstract screening and low consider: 1
    • abstract screening title and accuracy studies: 1, 2
    • abstract screening title and acute respiratory: 1, 2, 3, 4
    • abstract screening title and acute sars cov respiratory syndrome coronavirus: 1, 2
    • abstract screening title and low concern: 1
    • abstract screening title and low consider: 1
    • abstract title and accuracy studies: 1, 2, 3, 4, 5
    • abstract title and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • abstract title and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • abstract title and low concern: 1
    • abstract title and low consider: 1
    • accuracy studies and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accuracy studies and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • accuracy studies and low concern: 1
    • accuracy studies and low consider: 1